Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Email Updates

Search

AGORACOM News Flash

AGORACOM WIRE - MONDAY MAY 28TH, 2012

SONOMAX completes $3 million equity financing

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc. Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: Dr. Moro is doing 2 presentations

Agoraa
Rank: [?]
President
Points: [?]
11204
Rating: [?]
Votes: 30 Score: 4.0
  • Currently 4.0/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Dr. Moro is doing 2 presentations

posted on Oct 08, 08 04:43AM

Please note that Dr. Moro is doing 2 presentations at ISOBM 2008:

RECAF as a Cancer Marker for Gastrointestinal Diseases,
Ricardo Moro, BioCurex, Canada (Oral presentation, Workshop 5, that was unfortunately not included in the abstract book; its title can be found at: http://isobm08.umin.jp/ISOBM_Program... page number 20)

The other is entitled:
"A New RECAF ELISA and Its Correlation with the Chemiluminescence RECAF Assay" and it can be found in the Abstract book edited by Karger at http://content.karger.com/ProdukteDB... .



AGORACOM

New Message

Please login to post a reply

AGORACOM Quick Tips

AGORACOM Twitter. Follow our small but powerful market tips .. Follow and Prosper

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote